WallStSmart

Dell Technologies Inc (DELL)vsDanaher Corporation (DHR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Dell Technologies Inc generates 358% more annual revenue ($113.54B vs $24.78B). DHR leads profitability with a 14.9% profit margin vs 5.2%. DELL appears more attractively valued with a PEG of 0.87. DELL earns a higher WallStSmart Score of 75/100 (B+).

DELL

Strong Buy

75

out of 100

Grade: B+

Growth: 8.0Profit: 6.5Value: 8.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.61

DHR

Buy

58

out of 100

Grade: C

Growth: 4.0Profit: 6.0Value: 4.0Quality: 6.3
Piotroski: 4/9Altman Z: 2.36
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DELLUndervalued (+80.8%)

Margin of Safety

+80.8%

Fair Value

$644.85

Current Price

$211.64

$433.21 discount

UndervaluedFair: $644.85Overvalued
DHRSignificantly Overvalued (-27.4%)

Margin of Safety

-27.4%

Fair Value

$136.65

Current Price

$174.04

$37.39 premium

UndervaluedFair: $136.65Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DELL6 strengths · Avg: 9.5/10
Return on EquityProfitability
44.3%10/10

Every $100 of equity generates 44 in profit

Revenue GrowthGrowth
39.5%10/10

Revenue surging 39.5% year-over-year

EPS GrowthGrowth
57.3%10/10

Earnings expanding 57.3% YoY

Debt/EquityHealth
-11.9210/10

Conservative balance sheet, low leverage

Market CapQuality
$136.65B9/10

Large-cap with strong market position

PEG RatioValuation
0.878/10

Growing faster than its price suggests

DHR4 strengths · Avg: 8.3/10
Market CapQuality
$123.97B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
22.9%8/10

Strong operational efficiency at 22.9%

Free Cash FlowQuality
$1.08B8/10

Generating 1.1B in free cash flow

Areas to Watch

DELL2 concerns · Avg: 3.5/10
Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

Profit MarginProfitability
5.2%3/10

5.2% margin — thin

DHR3 concerns · Avg: 3.7/10
P/E RatioValuation
33.9x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
3.7%4/10

3.7% revenue growth

Return on EquityProfitability
7.1%3/10

ROE of 7.1% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : DELL

The strongest argument for DELL centers on Return on Equity, Revenue Growth, EPS Growth. Revenue growth of 39.5% demonstrates continued momentum. PEG of 0.87 suggests the stock is reasonably priced for its growth.

Bull Case : DHR

The strongest argument for DHR centers on Market Cap, Price/Book, Operating Margin. PEG of 1.12 suggests the stock is reasonably priced for its growth.

Bear Case : DELL

The primary concerns for DELL are Altman Z-Score, Profit Margin.

Bear Case : DHR

The primary concerns for DHR are P/E Ratio, Revenue Growth, Return on Equity.

Key Dynamics to Monitor

DELL profiles as a hypergrowth stock while DHR is a value play — different risk/reward profiles.

DELL carries more volatility with a beta of 1.06 — expect wider price swings.

DELL is growing revenue faster at 39.5% — sustainability is the question.

DELL generates stronger free cash flow (4.0B), providing more financial flexibility.

Bottom Line

DELL scores higher overall (75/100 vs 58/100) and 39.5% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Dell Technologies Inc

TECHNOLOGY · COMPUTER HARDWARE · USA

Dell Technologies Inc. designs, develops, manufactures, markets, sells and supports information technology solutions, products and services worldwide. The company is headquartered in Round Rock, Texas.

Visit Website →

Danaher Corporation

HEALTHCARE · DIAGNOSTICS & RESEARCH · USA

Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions.

Want to dig deeper into these stocks?